Antidepressant Withdrawal vs Relapse: How to Tell the Difference

Telling withdrawal apart from relapse is not an academic exercise. It changes what happens next. If your symptoms are read as relapse, the usual response is to go back up to a full dose and often to be told you may need the medication indefinitely. If the same symptoms are read as withdrawal, the response is to slow down, ease the drop, and let your brain catch up.

For decades these withdrawal effects were underestimated. The Maudsley Deprescribing Guidelines (Horowitz and Taylor, 2024) make the point plainly: withdrawal symptoms occur more often, are more severe, and last longer than was previously taught, and they have frequently been misread as relapse or as a brand new disorder. So if a prior attempt left you shaken, you were not imagining it, and you were very likely not relapsing on a slow schedule that simply was not slow enough.

When you take an antidepressant for months or years, your nervous system adapts around its presence. Remove the drug, or drop the dose, faster than the brain can re-adapt, and the temporary mismatch produces symptoms. This is a physical adjustment process, not a sign the original condition has returned.

A useful clue is that withdrawal often includes sensations that have nothing to do with depression or anxiety. People describe brain zaps (brief electric-shock feelings in the head, sometimes when moving the eyes), dizziness, nausea, flu-like aches, sweating, vivid dreams, and a strange wired-yet-exhausted feeling. Clinicians sometimes summarize the cluster with the mnemonic FINISH: Flu-like symptoms, Insomnia, Nausea, Imbalance, Sensory disturbances, and Hyperarousal. If you never had brain zaps or vertigo during your original depression, their arrival after a dose change points strongly toward withdrawal.

Onset timing is the single most useful distinction. Withdrawal usually begins within hours to a few days of stopping or reducing, because it tracks the falling drug level in your blood. Relapse, by contrast, is a gradual return of your original illness and typically takes weeks to build, rarely arriving the same week as a dose change.

Withdrawal also tends to come in waves. Symptoms appear within days of a reduction, build, peak within a week or two, then ease and often settle over the following weeks. Many people in withdrawal describe alternating windows (clearer days) and waves (rough patches). Relapse does not follow that wave-and-window rhythm. It is a slower, more sustained slide back into the specific symptoms you had before.

One more practical test: if symptoms ease quickly, within a day or two of going back to your last comfortable dose, that fast response fits withdrawal. A true depressive relapse does not resolve in 48 hours; antidepressants take weeks to lift mood. Quick relief on reinstatement is a reassuring sign you were dealing with withdrawal, not returning illness.

How fast withdrawal shows up, and how rough it tends to be, depends heavily on the specific drug, mostly because of its half-life (how long it lingers in your body). Verified ranges from the pharmacology literature:

• Short half-life, withdrawal tends to be faster and sharper: paroxetine (Paxil) around 24 hours, venlafaxine (Effexor) roughly 5 hours, duloxetine (Cymbalta) around 12 hours. Paroxetine and the SNRIs venlafaxine and duloxetine are consistently among the most associated with withdrawal difficulty.
• Intermediate: sertraline (Zoloft) around a day, citalopram and escitalopram in a similar range.
• Long half-life, withdrawal is often delayed and milder: fluoxetine (Prozac) at roughly 1 to 4 days, with its active metabolite lasting much longer.

The long-half-life case has a twist. With fluoxetine, withdrawal can be delayed by a couple of weeks because the drug clears so slowly, which can look confusingly like relapse if you are watching only the calendar. Knowing your drug's half-life helps you read your own timeline instead of guessing.

Here is the part that reframes a past failed attempt. Antidepressants do not act on the brain in a straight line. The relationship between dose and effect at the serotonin transporter is hyperbolic, not linear. At standard doses the transporter is already heavily occupied (around 80 percent at the usual minimum effective dose), so cutting from a high dose to a moderate one changes the brain's experience surprisingly little. But near the bottom of the dose range, each small milligram carries a large share of the remaining effect, so a seemingly tiny reduction can cause a disproportionately big drop in brain effect, and a big jolt of withdrawal.

This is exactly why so many people sail through the early, larger cuts and then hit a wall at low doses, often concluding their illness is back. It usually is not. It is the steepest part of the curve. The fix that the deprescribing literature points to is hyperbolic tapering: reductions that get smaller in absolute terms as the dose gets lower, so each step removes a similar share of brain effect rather than a similar number of milligrams. In practice this often looks like reducing by roughly 10 percent of the current dose at each step, with the steps shrinking as you go. The peer community Surviving Antidepressants helped popularize this 10 percent approach years before the academic guidelines caught up. If you tapered before by halving pills down to zero, the schedule, not your resolve, is the most likely reason it went badly.

There is a practical problem hyperbolic tapering runs into, and it deserves a straight answer: standard tablets simply do not come in the tiny sizes the bottom of the curve calls for. Getting from the smallest manufactured pill down to zero is where the real craft lives, and it is the stage where many people get stuck.

Common ways people reach small, precise doses, ideally arranged with a prescriber or pharmacist:

• Oral liquid versions of the drug, measured with an oral syringe, which allow very fine and gradual reductions.
• Compounded capsules or liquids made by a compounding pharmacy to a custom dose.
• Tapering strips, pre-packaged daily doses that step down gradually, used in several published hyperbolic-taper studies.
• Tablet splitting or dissolving a tablet in a measured volume of water to draw off a fraction.
• Bead counting for capsules such as venlafaxine, where the small beads are counted out to approximate a dose. This is fiddly and imprecise, so treat it as a rough method and confirm the formulation with your pharmacist.

None of this is exotic, but it is detailed, and the arithmetic is easy to get wrong when you are tired and anxious. This is the step where careful planning pays off most.

Everything above is about antidepressants. Benzodiazepines (such as diazepam, alprazolam, lorazepam, clonazepam) and the related Z-drugs are a separate, more serious situation, and they need extra caution. Abruptly stopping a benzodiazepine after regular use can trigger severe withdrawal that, unlike antidepressant withdrawal, can include seizures and can be life-threatening. Never stop a benzodiazepine suddenly on your own.

The long-standing reference here is the Ashton Manual, written by Professor Heather Ashton. Its core approach is to switch shorter-acting benzodiazepines to a long-acting one, usually diazepam (half-life up to around 200 hours), so the blood level falls smoothly, and then taper slowly in small steps. As a rough equivalence guide from the manual, about 0.5 mg alprazolam, 0.5 mg clonazepam, or 1 mg lorazepam each correspond to roughly 10 mg diazepam, though conversions are approximate and individual. If you are on a benzodiazepine, this is a conversation to have with a prescriber, supported by the Ashton Manual and communities like BenzoBuddies, not a do-it-yourself project.

You do not have to figure this out alone, and some of the best resources are free. Surviving Antidepressants offers detailed taper guidance and thousands of member case histories. BenzoBuddies focuses on benzodiazepine withdrawal. The Inner Compass Initiative and its Withdrawal Project provide plain-language education and peer support. The Ashton Manual remains the standard benzodiazepine reference, and the Maudsley Deprescribing Guidelines are the clinical text many prescribers now use. These communities did this work, often from lived experience, long before the guidelines existed, and they are genuine partners in getting off these drugs safely.

The one thing that turns all of this from overwhelming to doable is a concrete, written, day-by-day schedule with the actual doses and the physical method for each step. That is the piece Subside can help with: it can take your specific drug, dose, and pace and turn the hyperbolic math into a personalized schedule you can review with your prescriber, including how to reach those small end-of-taper doses. It is a planning aid, not a replacement for your clinician.

Whatever tool you use, go slow, track your symptoms so you can see the waves and windows for yourself, and adjust the pace to your own nervous system rather than the calendar.